Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
06/2008
06/04/2008CN100391939C Process for preparing metformin hydrochloride
05/2008
05/29/2008WO2008061456A1 The folacin-metformin compound and its manufacture
05/22/2008WO2008059159A1 Specific polyoxyalkylenediguanidines, cosmetic composition containing them, hair-straightening process
05/20/2008US7375088 culture product from a Streptomyces aizunensis strain; inhibitors of fungal cell growth and cancer cell growth; for lowering serum cholesterol and other steroids
05/14/2008CN101176861A Application of carbamidine series compounds in inverse floatation of bauxite
05/08/2008US20080108646 9-fluoro-6,7,-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid; optically pure isomers of Nadifloxacin; bactericide; systemic or topical Gram-positive, Gram-negative bacterial, mycobacterial and nosocomlal pathogen infections
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008CN101172957A Selective inhibitors of viral or bacterial neuraminidase
05/06/2008US7368605 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
05/02/2008CA2667426A1 Biguanide composition with low terminal amine
05/01/2008US20080103202 increasing creatine functionality and bioavailability in mammalian muscle, enhancing solubility and taste, enhancing athletic performance and lean body mass; is prepared at a temperature from 60 to 300 degrees C in a water or organic solution, or without any solvent
04/2008
04/30/2008EP1194633B1 Agent for coloring fibers and method for temporarily coloring fibers
04/29/2008CA2312990C Novel salts of metformin and method
04/23/2008EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/15/2008US7358359 Antibacterial agents
04/10/2008WO2008040979A1 Arginine derivatives with np-i antagonistic activity
04/10/2008WO2008040947A2 Soluble diazoalkane precursors
04/10/2008US20080085984 Producing carrier free, high purity, reduced side effects tumor imaging agent; reacting polydibutylchlorostannyl ethylstyrene with 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine then cyanamide
04/10/2008CA2664842A1 Arginine derivatives with np-i antagonistic activity
04/09/2008CN101160284A Organic compounds
04/08/2008CA2577439C Creatine-fatty acids
04/03/2008WO2008039162A1 Method for producing polyguanidines
04/03/2008US20080081856 Process for the preparation of polyphosphates of organic bases
04/02/2008EP1904428A2 New fluorinated compounds, their synthesis and use
04/01/2008US7351743 Therapeutic guanidines
03/2008
03/26/2008EP1902017A1 Antiviral compounds and methods
03/26/2008CN100376552C Method of extracting carbamyl ornithine from watermelon rind
03/25/2008US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies
03/25/2008CA2484638C Polyene polyketides and methods of production
03/20/2008WO2008033365A2 Amino ion releasing hydrogen bonded molecule
03/20/2008WO2008031456A1 Process for preparing hexamethylenebiscyanoguanidine and chlorhexidine
03/20/2008WO2008031212A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals
03/20/2008WO2008031199A1 Ionic compounds having bronsted acidity and uses thereof
03/20/2008US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
03/18/2008US7345168 reacting diphosphorus pentoxide, an organic base (melamine, guanidine, piperazine), and a water releasing agent (borax, aluminum or magnesium hydroxide, or oxalic or formic acid) to form polyphosphate salts; fire retardants for thermoplastic polyamide or polyester platics
03/13/2008WO2008029810A1 Phenylguanidine derivative or salt thereof, and pest control agent containing them as active ingredient
03/13/2008US20080064754 Amino ion releasing hydrogen bonded molecule
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/12/2008CN101142175A Peptidic compounds
03/06/2008WO2008026757A1 Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
03/06/2008US20080058549 Switchable solvents and methods of use thereof
03/06/2008CA2661272A1 Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
03/05/2008CN101134726A Derivant of salviol acidn A and its application as antioxidant
03/04/2008US7339077 Filtering solution of malic acid in anhydrous ethanol, reacting with creatine, centrifuging to obtain a wet dicreatine malate and a separated alcohol, and drying the wet dicreatine
02/2008
02/27/2008CN100371316C Process for preparing ethyl creatine hydrochloride
02/21/2008WO2008019594A1 Agmatine sulfate dihydrate and its medicinal use
02/21/2008US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
02/21/2008US20080044466 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
02/19/2008CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/13/2008EP1432677B1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
02/13/2008CN101121677A Agmatine sulfate dihydrate and medical use thereof
02/12/2008CA2577437C Creatine-fatty acids
02/07/2008WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/07/2008US20080032981 Aryl n-cyanoguanidines and methods related thereto
02/07/2008CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
01/2008
01/31/2008WO2008013555A1 Broad spectrum antimicrobial purification materials and methods for purifying fluids
01/30/2008CN101115714A Creatine hydroxycitric acids salts and methods for their production and use in individuals
01/29/2008US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/24/2008US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
01/23/2008EP1846368A4 Creatine hydroxycitric acids salts and methods for their production and use in individuals
01/23/2008CN101111475A 抗病毒化合物及方法 Antiviral compounds and methods
01/15/2008US7319104 hPPARs activators
01/10/2008WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/10/2008US20080009621 Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation
01/09/2008EP1874726A2 Organic compounds
01/09/2008EP1129064B1 Transfection reagents
01/08/2008CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
01/03/2008US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof
01/03/2008US20080003208 Creatine-ligand compounds and methods of use thereof
01/03/2008DE102006023649A1 Hydrophobe ionische Flüssigkeiten Hydrophobic Ionic Liquids
01/02/2008CN101096359A Polyarylsubstituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof
01/01/2008US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/2007
12/27/2007WO2007147252A1 Ship 1 modulator prodrugs
12/27/2007CA2656339A1 Ship 1 modulator prodrugs
12/21/2007WO2007146086A1 Creatine prodrugs, compositions and uses thereof
12/21/2007WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use
12/21/2007WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1268411B1 Method for producing n-methyl-n'-nitroguanidine
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/05/2007EP1272458B1 Arginine mimetics as factor xa inhibitors
11/2007
11/29/2007WO2007137107A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/29/2007WO2005009352A3 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
11/29/2007US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007US20070275905 Salts of trimebutine and n-desmethyl trimebutine
11/29/2007US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/27/2007US7301051 Creatine salts and method of making same
11/27/2007US7300921 with antibiotic activity; made by cultivation of Amycolatopsis orientalis
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/21/2007EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical
11/21/2007EP1267854B1 Highly selective inhibitors of the urokinase plasminogen activator
11/20/2007CA2206362C Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/15/2007WO2007129952A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds
11/15/2007WO2007095050A3 N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
11/15/2007US20070265453 Ionic Liquids Containing Guanidinium Cations
11/15/2007US20070265349 Medicinal association of a biguanine and a carrier, for example metformin and arginine
11/15/2007US20070265348 Therapeutic guanidines
11/14/2007EP1501379B1 New preservatives and protective systems
11/13/2007US7294743 Method for synthesis of acrylamide derivatives
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 54